---
title: "Shanghai RAAS today conducted a block trade at a discount, with 68.1766 million shares traded, totaling a transaction amount of 468 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246049086.md"
description: "On June 25th, Shanghai RAAS had a block trade of 68.1766 million shares, with a transaction amount of 468 million yuan, accounting for 74.69% of the total transaction amount on that day. The transaction price was 6.86 yuan, a discount of 0.44% compared to the market closing price of 6.89 yuan"
datetime: "2025-06-25T09:17:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246049086.md)
  - [en](https://longbridge.com/en/news/246049086.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246049086.md)
generator: "portal-rs"
---

# Shanghai RAAS today conducted a block trade at a discount, with 68.1766 million shares traded, totaling a transaction amount of 468 million yuan

On June 25th, Shanghai RAAS had a block trade of 68.1766 million shares, with a transaction amount of 468 million yuan, accounting for 74.69% of the total transaction amount that day. The transaction price was 6.86 yuan, a discount of 0.44% compared to the market closing price of 6.89 yuan

### Related Stocks

- [002252.CN](https://longbridge.com/en/quote/002252.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Here's Why We're Watching NOA Lithium Brines' (CVE:NOAL) Cash Burn Situation](https://longbridge.com/en/news/296350687.md)
- [14:41 ETNine Corboy & Demetrio Attorneys selected to 2027 The Best Lawyers in America®](https://longbridge.com/en/news/296644470.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**